1. Home
  2. ESCA vs CRDL Comparison

ESCA vs CRDL Comparison

Compare ESCA & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Escalade Incorporated

ESCA

Escalade Incorporated

SELL

Current Price

$18.64

Market Cap

257.2M

ML Signal

SELL

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.21

Market Cap

226.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESCA
CRDL
Founded
1922
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
257.2M
226.6M
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
ESCA
CRDL
Price
$18.64
$1.21
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $8.42
AVG Volume (30 Days)
24.0K
★ 1.5M
Earning Date
10-29-2026
11-12-2026
Dividend Yield
★ 3.27%
N/A
EPS Growth
★ 6.45
N/A
EPS
★ 1.00
N/A
Revenue
★ $180,541,000.00
N/A
Revenue This Year
$2.33
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$18.65
★ N/A
Revenue Growth
★ 2.71
N/A
52 Week Low
$11.41
$0.88
52 Week High
$23.07
$2.34

Technical Indicators

Market Signals
Indicator
ESCA
CRDL
Relative Strength Index (RSI) 34.70 21.87
Support Level $17.63 $0.96
Resistance Level $18.77 $1.35
Average True Range (ATR) 0.57 0.09
MACD -0.04 -0.05
Stochastic Oscillator 20.14 0.00

Price Performance

Historical Comparison
ESCA
CRDL

About ESCA Escalade Incorporated

Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting, and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are the United States, Canada, Australia, and Other regions.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

Share on Social Networks: